Explore
Upload

DocSlides is a free service to upload presentations and documents.

Upload Now

Search Results for 'Pfs Clinical'

Pfs Clinical published presentations and documents on DocSlides.

Median PFS: 2.6 months (95% CI, 1.7-3.5)

Median PFS: 2.6 months (95% CI, 1.7-3.5)

  • ceila
  • 5 Slides

Median PFS: 1.4 months (95% CI, 1.2-1.6) . Median ...

Beyond Secret Handshakes:

Beyond Secret Handshakes:

  • pasty-toler
  • 31 Slides

Affiliation-Hiding Authenticated Key Exchange. Fr...

2014 Oklahoma Business Summit

2014 Oklahoma Business Summit

  • marina-yarberry
  • 10 Slides

Sarah Roberts, Inasmuch Foundation, Program Offic...

Partnerships for Success

Partnerships for Success

  • test
  • 28 Slides

Creating Positive School Experiences And Develop...

Ray Jones

Ray Jones

  • danika-pritchard
  • 37 Slides

Director of Solutions Architecture and Field Enab...

Blinded Sample Size Re-estimation in a Phase III Study Inve

Blinded Sample Size Re-estimation in a Phase III Study Inve

  • luanne-stotts
  • 27 Slides

David Morgan (King’s College, London / Consulta...

Applying “Pay for Success” Social Impact Finance to Ear

Applying “Pay for Success” Social Impact Finance to Ear

  • luanne-stotts
  • 16 Slides

Janis Dubno, Voices for Utah Children. Andrea Phi...

Her-2 negative MBC

Her-2 negative MBC

  • conchita-marotz
  • 47 Slides

10/25/2016. Objectives. General principles. Endoc...

Interpretation of the Great Plains Polygonal Fault

Interpretation of the Great Plains Polygonal Fault

  • luanne-stotts
  • 0 Slides

Andy St-Onge, Calgary geophysicist@shaw.ca. (i) S...

Btk inhibition in Mantle cell Lymphoma & CLL

Btk inhibition in Mantle cell Lymphoma & CLL

  • test
  • 0 Slides

Simon Rule. Professor of Clinical . Haematology. ...

BELLE-3: A Phase III Study of

BELLE-3: A Phase III Study of

  • faustina-dinatale
  • 0 Slides

Buparlisib. and . Fulvestrant. in Postmenopausa...

Managing Advanced Renal Cell

Managing Advanced Renal Cell

  • debby-jeon
  • 0 Slides

Carcinoma: Balancing . Efficacy with Quality of L...

Jointly provided by & This activity is supported by educations grants from Novartis Pharmaceuticals Corporation, Pfizer, and Lilly. For further information concerning Lilly grant funding visit www.lillygrantoffice.com

Jointly provided by & This activity is supported by educations grants from Novartis Pharmaceuticals Corporation, Pfizer, and Lilly. For further information concerning Lilly grant funding visit www.lillygrantoffice.com

  • olivia-moreira
  • 67 Slides

Jointly provided by ...

Game Plan Trends in ovarian cancer

Game Plan Trends in ovarian cancer

  • alexa-scheidler
  • 59 Slides

Diagnostic work-up. Treatment. The most commonly ...

Nouveautés dans le CBNPC métastatique

Nouveautés dans le CBNPC métastatique

  • vizettan
  • 98 Slides

Celine Mascaux, MD, . PhD. Multidisciplinary . Onc...

Presentation

Presentation

  • wang
  • 1 Slides

pfs-full-vlSchema Taxo Fullwith capitalpfs-fullPre...

2022 Spring Oncology Conference

2022 Spring Oncology Conference

  • byrne
  • 62 Slides

Evolving Treatment Strategies. for CLL/SLL and MCL...

Update on Diagnosis and Treatments

Update on Diagnosis and Treatments

  • joanne
  • 29 Slides

of Multiple Myeloma. Kenneth C. Anderson, M.D.. J...

ESMO 2021 (Virtual) Congress Report

ESMO 2021 (Virtual) Congress Report

  • SnuggleBug
  • 122 Slides

Lung and gastrointestinal cancers. Slide numbers. ...

Considerations for Optimizing Transplant in Multiple Myeloma Patient Management

Considerations for Optimizing Transplant in Multiple Myeloma Patient Management

  • TravelingSoulmate
  • 77 Slides

PARAMESWARAN HARI MD. MEDICAL COLLEGE OF WISCONSIN...

Blinded Sample Size Re-estimation in a Phase III Study Investigating Progression Free Survival

Blinded Sample Size Re-estimation in a Phase III Study Investigating Progression Free Survival

  • naomi
  • 27 Slides

David Morgan (King’s College, London / Consultan...

YIR On Demand Lung Benjamin Levy, MD 

YIR On Demand Lung Benjamin Levy, MD 

  • jovita
  • 84 Slides

Assistant Professor. Johns Hopkins School of Medic...

Carfilzomib, Dexamethasone, and Daratumumab Versus Carfilzomib and Dexamethasone in Relapsed or Ref

Carfilzomib, Dexamethasone, and Daratumumab Versus Carfilzomib and Dexamethasone in Relapsed or Ref

  • willow
  • 15 Slides

Meletios Dimopoulos,. 1. Hang Quach,. 2. Maria-V...

Pay for Success: Innovative Financing to Improve Child Outcomes

Pay for Success: Innovative Financing to Improve Child Outcomes

  • dominic513
  • 20 Slides

Jennifer Tschantz; Early Childhood Research to Pra...

Company profi leProject name: Songwe Hill Rare Earths ProjectP

Company profi leProject name: Songwe Hill Rare Earths ProjectP

  • min-jolicoeur
  • 1 Slides

PFS well advanced, favourable topography, simple w...

Multiple Myeloma – Is It Now Curable?

Multiple Myeloma – Is It Now Curable?

  • celsa-spraggs
  • 23 Slides

Andrzej . J. . Jakubowiak, MD, PhD. Director, Mye...

Impact of Imatinib interruption & duration of prior Hyd

Impact of Imatinib interruption & duration of prior Hyd

  • pamella-moone
  • 21 Slides

Raafat. R. Abdel-. Malek. , MD, FRCR. Ass. Prof ...

Treatment of

Treatment of

  • natalia-silvester
  • 21 Slides

Biliary. Cancers. Abby B. Siegel, MD, MS . Colum...

Product Labels – Defending the Use of Processed Foods

Product Labels – Defending the Use of Processed Foods

  • min-jolicoeur
  • 33 Slides

Michigan Department of Education. School Nutritio...

Series:

Series:

  • lois-ondreau
  • 53 Slides

From Tax Preparer to Financial Planner: The Road ...

MEK Inhibitors and their potential role in relapsed NSCLC

MEK Inhibitors and their potential role in relapsed NSCLC

  • debby-jeon
  • 30 Slides

Ranee Mehra, MD. Fox Chase Cancer Center. Philade...

Department of GI Medical Oncology

Department of GI Medical Oncology

  • danika-pritchard
  • 38 Slides

Does . the New EPOC trial . eliminate. . Anti. -...

Update on transplant-ineligible patients:

Update on transplant-ineligible patients:

  • trish-goza
  • 34 Slides

Which . regimens are best?. Suzanne Lentzsch MD, ...

Chee Lee,

Chee Lee,

  • olivia-moreira
  • 29 Slides

MBBS (Hons), . MMedSci. (. Clin. . Epid. ), . M...

ASCO Update 2012:

ASCO Update 2012:

  • tatyana-admore
  • 71 Slides

Gastrointestinal Malignancies. Thomas J. Semrad M...

It's Never Too Early (or Too Late) To Specialize: Is a Care

It's Never Too Early (or Too Late) To Specialize: Is a Care

  • danika-pritchard
  • 44 Slides

[presenter name/business name]. [presentation dat...

Acquired Resistance Patient Forum

Acquired Resistance Patient Forum

  • test
  • 32 Slides

September 6, 2014 | Boston. In ALK, ROS1 & EG...

Novel

Novel

  • tatiana-dople
  • 28 Slides

Agents . for . Indolent . L. ymphoma . and . Mant...

Calculating the Contribution to the Meal Pattern:

Calculating the Contribution to the Meal Pattern:

  • pamella-moone
  • 54 Slides

Product Formulation Statements. Webinar March 27,...

Architecture

Architecture

  • ellena-manuel
  • 19 Slides

Rajesh. Components of Database Engine. Issue Quer...

Copyright © 2024 DocSlides. All Rights Reserved